首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 赵林华
2023
CA
Microbiome and metabolome dysbiosis analysis in impaired glucose tolerance for the prediction of progression to diabetes mellitus
JGG, 10.1016/j.jgg.2023.08.005
CA
Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism
Gut Microbes, 10.1080/19490976.2023.2236749
点击查看热心肠日报解读
CA
Visualizing temporal dynamics and research trends of macrophage-related diabetes studies between 2000 and 2022: a bibliometric analysis
Front Immunol, 10.3389/fimmu.2023.1194738
CA
Probiotic Fermentation of Herbal Medicine: Progress, Challenges, and Opportunities
AM J CHIN MED, 10.1142/S0192415X23500519
CA
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis
BMJ OPEN DIAB RES CA, 10.1136/bmjdrc-2022-003198
CA
Qimai Feiluoping decoction inhibits mitochondrial complex I-mediated oxidative stress to ameliorate bleomycin-induced pulmonary fibrosis
PHYTOMEDICINE, 10.1016/j.phymed.2023.154707
CA
Clinical potential and mechanistic insights of mulberry (Morus alba L.) leaves in managing type 2 diabetes mellitus: Focusing on gut microbiota, inflammation, and metabolism
J ETHNOPHARMACOL, 10.1016/j.jep.2023.116143
2022
CA
Effect of natural polyphenols in Chinese herbal medicine on obesity and diabetes: Interactions among gut microbiota, metabolism, and immunity
Front Nutr, 10.3389/fnut.2022.962720
CA
Research status and trends of the diabetic cardiomyopathy in the past 10 years (2012-2021): A bibliometric analysis
Front Cardiovasc Med, 10.3389/fcvm.2022.1018841
CA
Herbal tea, a novel adjuvant therapy for treating type 2 diabetes mellitus: A review
FPHAR, 10.3389/fphar.2022.982387
CA
Global research trends on the links between the gut microbiota and diabetes between 2001 and 2021: A bibliometrics and visualized study
FMICB, 10.3389/fmicb.2022.1011050
CA
Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Adjuvant Treatment of Coronary Heart Disease in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis with Trial Sequential Analysis
J DIABETES RES, 10.1155/2022/2545476
CA
Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases
FRONT MED-LAUSANNE, 10.3389/fmed.2022.860681
CA
Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics
FRONT ENDOCRINOL, 10.3389/fendo.2022.817147
CA
Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples
FCIMB, 10.3389/fcimb.2022.855075
CA
Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis
Pharmacol Res, 10.1016/j.phrs.2022.106111
CA
Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology
EUR J PHARMACOL, 10.1016/j.ejphar.2022.174769
2021
CA
Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus
J DIABETES RES, 10.1155/2021/1655336
CA
Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus
J DIABETES RES, 10.1155/2021/1655336
CA
Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus
J DIABETES RES, 10.1155/2021/1655336